Novel therapeutic strategies via the apoptosis pathways to resolve chronic eosinophilic inflammation.
Physiologic cell death is a necessary process to maintain correct cell numbers. Alterations in this process may contribute to the pathogenesis of a number of human diseases. During the past few years, evidence has been adduced indicating that eosinophilic disorders are associated with a defect in eosinophil apoptosis. Here we review our recent progress in understanding the processes regulating eosinophil apoptosis, and the implications of these results for novel therapeutic possibilities.